Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment
Elevated ALT levels during clinical trials led researchers to use quantitative systems toxicology software to better understand potential underlying mechanisms ... -Today at 08:34 am- MarketScreener